Growth Vision Asset Management (GVAM) offers investment management services to high-net-worth individuals, investment clubs, and institutional investors. GVAM invests solely in publicly traded biotech stocks. GVAM does not tailor investment strategies for individual clients, but thoroughly discusses its strategy, investment process, and risks with clients to ensure suitability. GVAM may act as a subadviser to other advisors in the future.
| Portfolio Value | Annual Fee |
|---|---|
| Any | 1.40% |
GVAM charges a 1.4% annualized management fee and a 20% annual performance fee for the net gain above 8%. Fees can be negotiated.